Utility of Metagenomic Next-Generation Sequencing for Diagnosis of Infectious Diseases in Critically Ill Immunocompromised Pediatric Patients
Infection and Drug Resistance · 2024-08 · Volume 17 · 3579-3591
DOI: 10.2147/idr.s472129 ↗Kurz gefasst
Fachartikel in der Zeitschrift Infection and Drug Resistance, 2024-08. Verfasst von Xiangzhi Xu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric Intensive Care Unit, Children's Hospital, Zhejiang University School of Medicine, Hangzhou, People's Republic of China. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Purpose
Infections cause high rates of illness and death in children worldwide. However, studies on the clinical value of metagenomic next-generation sequencing (mNGS) for immunocompromised children are still limited. Patients and Methods: From June 2021 to December 2023, 119 samples were collected at Pediatric Intensive Care Unit (PICU) of a single-center pediatric hospital and classified into two groups based on their immune states. We compared the diagnostic performance of mNGS and conventional microbiological test (CMT) for pathogen identification, and assessed the clinical impacts of mNGS.
Results
Among the 119 samples, 48 (40.34%) belonged to the immunocompromised children. mNGS had a higher positivity rate than CMT (76.47% vs 55.46%, P = 0.0006). The positive percent agreement (PPA) of mNGS for immunocompromised children was higher compared to immunocompetent children (95.24% vs 77.78%). The most common pathogens for immunocompromised patients were gram-negative bacteria and herpesvirus. However, immunocompetent children showed a higher detection rate for gram-positive bacteria and respiratory viruses. Furthermore, the proportions of the positive impact of mNGS results were significantly higher in immunocompromised patients compared to immunocompetent patients for both diagnosis (91.67% vs 57.75%) and treatment (95.83% vs 64.79%) (P < 0.0001). Immunocompromised state, length of hospital stays, times stay in ICU, Pediatric Risk of Mortality (PRISM) score, neutrophil percentage (NEUT%) and the ratio of arterial oxygen partial pressure to fractional inspired oxygen (PaO2/FiO2) were considered independent factors for poor prognosis in critically ill pediatric patients.
Conclusion
In patients from PICU, mNGS had a greater clinical significance in immunocompromised children compared to immunocompetent children. mNGS technology is an important auxiliary method for achieving accurate diagnosis and treatment of critically ill pediatric patients.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pediatric Intensive Care Unit, Children's Hospital, Zhejiang University School of Medicine, Hangzhou, People's Republic of China.
- WillingMed Technology (Beijing) Co., Ltd, Beijing, People's Republic of China.
ORCID-Profile: Xiangzhi Xu, Yafeng Zheng
Zitieren
APA
Xu, X., Zheng, Y., Zhang, X., Zhang, C., Gai, W., & Yang, Z. (2024). Utility of Metagenomic Next-Generation Sequencing for Diagnosis of Infectious Diseases in Critically Ill Immunocompromised Pediatric Patients. Infection and Drug Resistance, Volume 17, 3579-3591. https://doi.org/10.2147/idr.s472129
Vancouver
Xu X, Zheng Y, Zhang X, Zhang C, Gai W, Yang Z. Utility of Metagenomic Next-Generation Sequencing for Diagnosis of Infectious Diseases in Critically Ill Immunocompromised Pediatric Patients. Infection and Drug Resistance. 2024;Volume 17:3579-3591. doi:10.2147/idr.s472129
BibTeX
@article{Xu2024,
author = {Xu, Xiangzhi and Zheng, Yafeng and Zhang, Xiaojing and Zhang, Chenmei and Gai, Wei and Yang, Zihao},
title = {Utility of Metagenomic Next-Generation Sequencing for Diagnosis of Infectious Diseases in Critically Ill Immunocompromised Pediatric Patients},
journal = {Infection and Drug Resistance},
year = {2024},
volume = {Volume 17},
pages = {3579--3591},
doi = {10.2147/idr.s472129}
}
EUVIMED